Data updated: Mar 10, 2026
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
ETHINYL ESTRADIOL
Approved 2009-11-06
11
Indications
--
Phase 3 Trials
16
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2009-11-06
- Routes
- ORAL-28, ORAL, ORAL-21
- Dosage Forms
- TABLET
Companies
Website: ↗
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL Approval History
Loading approval history...
What NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL Treats
11 FDA approvalsOriginally approved for its first indication in 2009 . Covers 11 distinct patient populations.
- Other (11)
Other
(11 approvals)- • Approved indication (Nov 2009)Letter
- • Approved indication (Mar 2010)Letter
- • Approved indication (Nov 2013)
- • Approved indication (Nov 2013)
- • Approved indication (Feb 2015)
- • Approved indication (Feb 2015)
- • Approved indication (Apr 2015)
- • Approved indication (Jan 2016)
- • Approved indication (Dec 2016)
- • Approved indication (Feb 2017)
- • Approved indication (Jun 2018)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.